A screening methodology based on Random Forests to improve the detection of gene-gene interactions.
The search for susceptibility loci in gene-gene interactions imposes a methodological and computational challenge for statisticians because of the large dimensionality inherent to the modelling of gene-gene interactions or epistasis. In an era in which genome-wide scans have become relatively common, new powerful methods are required to handle the huge amount of feasible gene-gene interactions and to weed out false positives and negatives from these results. One solution to the dimensionality problem is to reduce data by preliminary screening of markers to select the best candidates for further analysis. Ideally, this screening step is statistically independent of the testing phase. Initially developed for small numbers of markers, the Multifactor Dimensionality Reduction (MDR) method is a nonparametric, model-free data reduction technique to associate sets of markers with optimal predictive properties to disease. In this study, we examine the power of MDR in larger data sets and compare it with other approaches that are able to identify gene-gene interactions. Under various interaction models (purely and not purely epistatic), we use a Random Forest (RF)-based prescreening method, before executing MDR, to improve its performance. We find that the power of MDR increases when noisy SNPs are first removed, by creating a collection of candidate markers with RFs. We validate our technique by extensive simulation studies and by application to asthma data from the European Committee of Respiratory Health Study II.
De Lobel
Lizzy
L
Department of Applied Mathematics and Computer Science, Ghent University, Ghent, Belgium. Lizzy.Delobel@ugent.be
Geurts
Pierre
P
Baele
Guy
G
Castro-Giner
Francesc
F
Kogevinas
Manolis
M
Van Steen
Kristel
K
D000465:Algorithms; D001249:Asthma / Q000235:genetics; D019295:Computational Biology / Q000379:methods*; D003198:Computer Simulation; D003663:Decision Trees; D004843:Epistasis, Genetic; D005060:Europe; D015870:Gene Expression; D056726:Genetic Association Studies; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D008957:Models, Genetic; D058011:Multifactor Dimensionality Reduction; D020641:Polymorphism, Single Nucleotide; D013223:Statistics as Topic
D005819:Genetic Markers
Hum Mol Genet. 2006 May 15;15(10):1667-79
16600990
Nat Genet. 2003 Nov;35(3):258-63
14566338
Genet Epidemiol. 2009 Jan;33(1):87-94
18671250
Hum Hered. 2009;67(3):183-92
19077437
J Med Genet. 2009 Mar;46(3):159-67
18285428
Am J Hum Genet. 2006 Jan;78(1):15-27
16385446
Nat Rev Genet. 2004 May;5(5):376-87
15143320
Biometrics. 2000 Mar;56(1):52-8
10783776
Am J Hum Genet. 2001 Jul;69(1):138-47
11404819
Am J Physiol Lung Cell Mol Physiol. 2006 Nov;291(5):L1005-17
16829631
Nat Genet. 2005 Apr;37(4):413-7
15793588
Eur Respir J. 2008 Aug;32(2):350-61
18385169
Science. 2004 Apr 9;304(5668):300-4
15073379
Genet Epidemiol. 2003 Feb;24(2):150-7
12548676
Hum Hered. 2003;56(1-3):73-82
14614241
Genet Epidemiol. 2005 Feb;28(2):171-82
15593090
Biochem J. 2003 Jul 1;373(Pt 1):179-89
12662155